Stock listing

NASDAQ:VRAX Virax Biolabs Group Limited Stock

Home listing (NASDAQ) of Virax Biolabs Group Limited

Follow Virax Biolabs Group Limited into a list and get an email when it puts out news.

Share price · NASDAQ:VRAX

$1.40 USD -0.05 (-3.4%)

Close on Oct 19, 2026

Past 3 months -55.0% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$1.38 – $1.65 USDOct 19, 2026
Volume
12,088 sharesOct 19, 2026
Market value
$1.88M USDAt the close on Oct 19, 2026 · price × 1.34M shares outstanding
Virax Biolabs Group Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:VRAX · Home$1.40 USD-0.05 (-3.4%)12,088$1.50$1.648$1.38$1.45Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:VRAX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.40-0.05-3.4%$1.50$1.648$1.3812,088
$1.45-0.17-10.5%$1.62$1.64$1.3840,685
$1.62-0.03-1.8%$1.66$1.76$1.5544,169
$1.65-0.088-5.1%$1.77$1.78$1.6138,555
$1.738-0.112-6.0%$1.80$1.86$1.7243,745
$1.85-0.02-1.1%$1.81$1.90$1.7871,000
$1.87-0.12-6.0%$1.92$1.94$1.8187,600
$1.99-0.12-5.7%$2.13$2.13$1.9350,800
$2.11+0.08+3.9%$2.02$2.18$1.83271,500
$2.03-0.37-15.4%$2.33$2.33$1.83310,500
$2.40+0.20+9.1%$2.53$3.34$2.162,895,100
$2.20-0.04-1.8%$2.21$2.25$2.1319,600
$2.24+0.056+2.6%$2.18$2.374$2.1830,800
$2.184-0.046-2.1%$2.25$2.27$2.1319,500
$2.23-0.084-3.6%$2.27$2.395$2.0494,000
$2.314-0.081-3.4%$2.35$2.35$2.305,500
$2.395-0.045-1.8%$2.38$2.60$2.3813,400
$2.44-0.11-4.3%$2.277$2.47$2.27720,600
$2.55+0.05+2.0%$2.52$2.60$2.5014,300
$2.50+0.19+8.2%$2.38$2.65$2.28551,000
$2.31-0.23-9.1%$2.48$2.54$2.14570,800
$2.54+0.01+0.4%$2.50$2.58$2.4914,600
$2.53+0.04+1.6%$2.53$2.60$2.5016,500
$2.49-0.10-3.9%$2.59$2.59$2.4523,800
$2.59-0.02-0.8%$2.66$2.775$2.5824,400
$2.61-0.06-2.2%$2.59$2.75$2.5828,900
$2.67-0.18-6.3%$2.77$2.84$2.6036,900
$2.85+0.12+4.4%$2.73$2.92$2.7072,000
$2.73+0.10+3.8%$2.66$2.76$2.6338,300
$2.63+0.005+0.2%$2.60$2.66$2.5629,000
$2.625+0.065+2.5%$2.54$2.635$2.5421,800
$2.56+0.015+0.6%$2.625$2.69$2.5240,200
$2.545-0.055-2.1%$2.56$2.61$2.5424,400
$2.60-0.22-7.8%$2.82$2.835$2.5686,200
$2.820.000.0%$2.92$2.92$2.7716,800
$2.82-0.12-4.1%$2.89$2.945$2.7536,600
$2.94+0.17+6.1%$2.80$2.95$2.7244,200
$2.77-0.14-4.8%$2.87$2.94$2.7391,500
$2.91-0.09-3.0%$3.00$3.00$2.9035,900
$3.00-0.19-6.0%$3.14$3.19$2.9080,900
$3.19-0.26-7.5%$3.51$3.51$3.14119,000
$3.45+0.27+8.5%$3.20$3.64$3.10499,000
$3.18+0.42+15.2%$3.24$4.29$2.8118,126,600
$2.76-0.05-1.8%$2.78$2.82$2.7624,100
$2.81-0.05-1.7%$2.81$2.835$2.8026,600
$2.86+0.04+1.4%$2.849$2.89$2.7851,300
$2.82+0.04+1.4%$2.76$2.89$2.7131,400
$2.78-0.09-3.1%$2.89$2.89$2.7638,300
$2.87-0.01-0.3%$2.83$2.91$2.8320,500
$2.88-0.10-3.4%$2.99$2.99$2.7935,700
$2.98+0.21+7.6%$2.81$2.981$2.7165,200
$2.77-0.14-4.8%$2.76$2.907$2.7479,600
$2.91-0.07-2.3%$3.10$3.10$2.8449,000
$2.98+0.04+1.4%$2.84$3.07$2.84141,000
$2.94+0.32+12.2%$2.62$2.94$2.551527,600
$2.62-0.18-6.4%$2.78$2.842$2.5865,400
$2.80-0.13-4.4%$2.95$2.95$2.7542,200
$2.93+0.04+1.4%$2.91$3.04$2.8833,900
$2.89-0.21-6.8%$3.04$3.056$2.8172,400
$3.10-0.09-2.8%$3.18$3.288$3.0052,900
$3.190.000.0%$3.17$3.19$3.1186,200
$3.19-0.45-12.4%$3.53$3.55$3.11183,600
$3.64-0.24-6.2%$3.75$3.84$3.64119,500
$3.88-0.01-0.3%$3.85$3.95$3.73277,700
$3.89+0.10+2.6%$3.71$4.11$3.60315,100
Ticker
NASDAQ:VRAX
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 20, 2026

Closed $3.89 (+2.6%) on Jul 20, 2026

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Jul 16, 2026

Closed $3.90 (+13.0%) on Jul 16, 2026

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Jul 10, 2026

Closed $4.07 (-0.2%) on Jul 13, 2026

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Jul 9, 2026

Closed $6.36 (+100.0%) on Jul 9, 2026

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

Jul 9, 2026

Closed $6.36 (+100.0%) on Jul 9, 2026

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

Jun 24, 2026

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

May 26, 2026

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Mar 31, 2026

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 4, 2025

Virax Biolabs Group Limited Announces $5 Million Private Placement

Dec 3, 2025

All Virax Biolabs Group Limited news

Financings

  • Ordinary shares on exercise of preferred investment options

    Jul 16, 2026

    Closed: US$3.3M in the latest tranche · US$6 a share · Warrants at US$6 · H.C. Wainwright & Co.

    Dealers: H.C. Wainwright & Co. (lead)

    Use of proceeds: Working capital for general corporate purposes

    Announced Jul 9, 2026 · Closed Jul 10, 2026 · Closed Jul 16, 2026

Read by 6ix AI from the company's releases

Decks

Virax Biolabs Group Limited on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
12 in the last 12 months · 45 in all · newest Jul 20, 2026 · oldest 2022
Decks
3 decks · latest September 2026

Where Virax Biolabs Group Limited is listed

ListingExchangeCountryCurrency
NASDAQ:VRAX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:VRAXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Virax Biolabs Group Limited.